|
|
|
|
|
|
|
|
|
|
open access updated review September 30, 2016
In conclusion, the present study suggests that metformin exposure is associated with reduced risk of ovarian cancer and has a tendency to improve survival in female patients with diabetes. Well-designed randomized clinical trials are needed to further confirm the findings.
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.